Purpose: Bimatoprost 0,03% is a prostamide with a good efficacy like an ocular hypotensive agent. A collateral effect observed using this drug is the presence of hyperemia around 30 to 40 % of the cases. In this study...Purpose: Bimatoprost 0,03% is a prostamide with a good efficacy like an ocular hypotensive agent. A collateral effect observed using this drug is the presence of hyperemia around 30 to 40 % of the cases. In this study we analysed histopathologically conjunctival segments of patients with hyperemia during the use of bi-matoprost and submited to cataract surgery to evaluate the presence or not of acute inflammatory cells in these cases. Methods: Patients were divided in two groups. Group 1 ( study group)展开更多
Purpose: Conjunctival hyperemia has been reported as a frequent side effect of bimatoprost, a prostamide with efficacious ocular hypotensive action. To investigate the possible inflammatory basis of the hyperemia, we ...Purpose: Conjunctival hyperemia has been reported as a frequent side effect of bimatoprost, a prostamide with efficacious ocular hypotensive action. To investigate the possible inflammatory basis of the hyperemia, we analysed, by means of light microscopy, the conjunctival specimens of patients who developed ocular hyperemia during bimatoprost therapy and who underwent cataract surgery. Methods: Patients were divided in two groups;展开更多
文摘Purpose: Bimatoprost 0,03% is a prostamide with a good efficacy like an ocular hypotensive agent. A collateral effect observed using this drug is the presence of hyperemia around 30 to 40 % of the cases. In this study we analysed histopathologically conjunctival segments of patients with hyperemia during the use of bi-matoprost and submited to cataract surgery to evaluate the presence or not of acute inflammatory cells in these cases. Methods: Patients were divided in two groups. Group 1 ( study group)
文摘Purpose: Conjunctival hyperemia has been reported as a frequent side effect of bimatoprost, a prostamide with efficacious ocular hypotensive action. To investigate the possible inflammatory basis of the hyperemia, we analysed, by means of light microscopy, the conjunctival specimens of patients who developed ocular hyperemia during bimatoprost therapy and who underwent cataract surgery. Methods: Patients were divided in two groups;
